Pmda - Pharmaceuticals and Medical Devices Agency

Regulatory Science/The Science Board/Standard Development

The 2nd Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

Press Release

October 4, 2021 from 2pm to 3:45pm
Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

  1. Lecture by Subcommittee Member and Discussion
    • Drug Discovery Based on the Murine POC (An Example Using Cytotoxic T Lymphocyte EVs) (Special Lecturer SEO, Member of the Subcommittee)
    • Possibilities and Problems of Engineered Exosomes (Professor HANAYAMA, Vice Chairperson of the Subcommittee)
  2. Issues and Assignment Table of Report on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
  3. Others
List of Handouts
  • Document 1 Lecture Material by Special Lecturer SEO (Member of the Subcommittee)
  • Document 2 Lecture Material by Professor HANAYAMA (Vice Chairperson of the Subcommittee)
  • Document 3 Lecture Material by Professor TAKAKURA (Chairperson of the Subcommittee)
  • Ref.1 Letter to the Editor Published in British Journal of Clinical Pharmacology